cefotiam hydrochloride Supplier & Distributor of CAS# 61622-34-2

cefotiam hydrochloride

Quantity:

add to inquiry

Product Description:

Cefotiam hydrochloride is a third-generation cephalosporin antibiotic used to treat bacterial infections.

Applications & Uses:

CAS#:

61622-34-2

SYNONYM:

cefotiam;cefotiam hydrochloride;SCE-963

FORMULA:

C18H24N8O5S3

PRODUCT TYPE:

HAZARD:

Irritant

CATEGORIES:

Pharmaceutical

Technical Specifications

Appearance :

White to off-white powder

Melting point, °C :

137-139

Molecular weight, g/mol :

480.91

Cefotiam hydrochloride is a broad-spectrum cephalosporin antibiotic renowned for its effectiveness in combating a wide range of bacterial infections. This semi-synthetic, beta-lactam antibiotic is an essential component in the healthcare sector due to its potent antibacterial properties. It operates by inhibiting bacterial cell wall synthesis, leading to the disruption of the growth and reproduction of pathogens. Cefotiam hydrochloride is primarily used in clinical settings to treat infections caused by Gram-positive and Gram-negative bacteria, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and intra-abdominal infections. The compound is praised for its therapeutic efficacy and is often preferred in scenarios where a robust and reliable antibiotic solution is paramount. With its well-tolerated safety profile and reliable performance, cefotiam hydrochloride is a vital resource in modern medicine, aiding healthcare professionals in their fight against bacterial diseases.

Details

CAS #

61622-34-2

CATEGORIES:

Pharmaceutical

Having Trouble Finding A Specific Product?
We Will Find It For You!

GET A QUICK QUOTE NOW

Recent Searches

Trending Now

Markets

Process Point

Process Point, LLC.

500 Office Center Drive, Suite 803
Fort Washington, PA 19034
Phone: 855-453-6208

Email: hello@processpointchem.com

Your Product Inquiry

You have not added any products to your inquiry.

Click Here to search our product database.

Unsent Inquiries: